PMC full text:
FIG. 2.
Anti-SARS-CoV-specific neutralization antibody response in BALB/c mice after ADS-MVA vaccinations. Each mouse was designated with a number such as M260. The animals were immunized i.m. twice, 3 weeks apart, with 2 × 106 TCID50 (M260 and M262) or 2 × 107 TCID50 of ADS-MVA per mouse (M263, M264, and MM1 to MM4) or 2 × 107 TCID50 of ADC-MVA (M265 to M268). Two control mice (N1 and N2) only received saline under the same immunization schedule.